EGLATOPRUTUG
UNII B4IT1FAK55

Substance Identification & Data

This profile provides standardized clinical and technical data for Eglatoprutug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B4IT1FAK55.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2518200-21-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B4IT1FAK55
CAS Registry Number
2518200-21-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EGLATOPRUTUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12165
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eglatoprutug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EGLATOPRUTUG

Common Names & Synonyms

EGLATOPRUTUG [INN]
IMMUNOGLOBULIN G1 (DE-447-LYSINE), ANTI-(HUMAN C-KIT PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL HF12 10-9B8 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HF12 10-9B8 .KAPPA.-CHAIN, DIMER